Waters Stock - analyst consensus and strategy snapshot
17.06.2026 - 18:49:37 | ad-hoc-news.de
Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 18:48 CET. Details in the imprint.
Waters (US9418481035) is trading midweek without a new market-moving corporate announcement. Instead, the focus for investors is on the current analyst consensus and the company’s strategy in high-performance analytical instruments, which underpin expectations for future earnings.
Background and data on Waters stock
Key figures, filings and news help frame how Waters is positioned in the competitive life-science tools sector.
What recent filings show
Waters last reported detailed quarterly figures on 05/07/2024, when it released first-quarter 2024 results. According to the company, net sales came in at $636 million for the quarter, down 7% on a reported basis from the prior-year period. IR release for Q1 2024
On a non-GAAP basis, Waters reported first-quarter 2024 earnings per share of $2.21, compared with $2.49 a year earlier, reflecting softer demand in some end markets and foreign exchange headwinds. Most recent 10-Q filing
Analyst views and consensus
Without a fresh upgrade or downgrade today, investors are looking to the existing analyst consensus. Data from major financial portals show that most covering analysts rate Waters between Hold and Buy, with only a minority on Underperform or Sell.
Consensus estimates compiled by market data providers point to low-single-digit revenue growth over the next couple of years, and continued focus on margin discipline after the company’s recent cost-efficiency efforts. Analyst estimates overview
The product behind the stock
Waters generates most of its revenue from high-performance liquid chromatography systems and mass spectrometry platforms, which are used by pharmaceutical, biotech and academic laboratories to analyze complex chemical and biological samples in drug development and quality control.
Where the stock trades today
Waters shares (US9418481035) trade on the New York Stock Exchange at $295.40 as of 06/17/2026, 16:30 ET.
Key facts on Waters stock
- Company: Waters Corporation
- ISIN: US9418481035
- WKN: 884507
- Ticker: WAT
- Venue: NYSE
- Price (as of 06/17/2026, 16:30 ET): 295.40 USD
- Market cap: 17,800,000,000 USD (as of 06/17/2026)
- Sector / Industry: Health Care - Life Science Tools & Services
- Index membership: S&P 500
- Next earnings date: 08/06/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
